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INTRODUCTION
Cardio vascular diseases mainly ischaemic heart diseases and
stroke are the leading causes of death in world.
The genetic and lifestyle risk factors of these diseases are well
known and include hypercholesterolemia, hypertension, smoking, obesity
and inadequate physical activity.
Atherosclerotic cardiovascular diseases is a major cause for
morbidity and mortality in adult population.
Hyperlipidemia may cause complications such as stroke, kidney
failure, coronary artery diseases.
Altered lipid levels was the well known factor in coronary heart
diseases and this process is considered to begin in early life and
progressed silently over decades.
In the 1980^s English physician and epidemiologist David Barker
of the university of Southampton formulated a hypothesis stating that the
intrauterine environment influences the patterns of physiological process
in the foetus that in certain conditions may influence the presence of
medical disorders in future life.
Barker et  al  demonstrated that  low birth weight  is  correlated with
increased prevalence of cardio vascular diseases in future.
He analysed data from Hertfordshire, concerning the birth weight
of all new borns from 1911 and their development through the infancy
period, barker noted that over a period of 60 years the people whose birth
weight was higher at birth had lower mortality from cardiovascular
diseases.
This was in synchronization with foetal origin hypothesis and
reflects the phenomenon that programming whereby a stimulation or any
insult during critical period of intrauterine life could result in alternation
of physiology and metabolism during adult life.
Studies in human have shown that men and women with low birth
weight  are at  increased risk of coronary artery heart diseases.
Human foetuses are known to permanently change their physiology
and metabolism to adapt to limited supply of nutrients inutero.
Concentrations of cord blood lipoproteins levels are influenced by
foetal malnutrition and prematurity.
These programmed changes can later be the cause for the origin of
diseases like coronary artery diseases, hypertension and diabetes mellitus.
It is well documented that atherosclerosis starts in childhood and
there is evidence that this association with adult level may originate at
birth, so assessment of serum lipid levels in neonates might be of
importance.
Abnormal lipoprotein profile in newborn may persist into adult life
so young age can be viewed as an opportunity to begin preventable
interventions to change risk factors for cardiovascular diseases.
Hence this study will be conducted to compare umbilical cord
blood lipid profile between   normal and low birth weight babies.
High concentrations of triglycerides rich lipoproteins are seen with
infants with low birth weight. A study done by Dr. Anomika gora, Dr.
Plak gupta, Dr.M.L. Gupta. Scholar journal of  applied medical sciences.
Sch J.App Med Sci 2017 ;5(7c): 2662- 2665.
Many studies have confirmed the importance of proper intrauterine
development and all the factors that affect it will affect the future life.
Donega et al reported that the concentration of total cholesterol,
LDL, HDL, apolipoproteins were higher in preterm than in term babies.
whereas triglycerides level will be higher in preterm babies than in term
babies.
Therefore it is reasonable to search for the first risk factors of life
style diseases as early as possible in the neonatal period.
The aim of this study is to examine the possible relationships
among several foetal and maternal factors and the neonatal cord blood
lipid profile inorder to detect any possible characteristics that may
predispose neonates to higher risk of coronary heart diseases in future.
There are a number of maternal as well as fetal high risk factors,
which adversely affect the fetal-placental unit, thus compromising its
functions. Some of the well recognized maternal as well as fetal factors
are pregnancy induced hypertension, chronic maternal diseases like
diabetes mellitus hypertension etc, ante-partum hemorrhage, prolonged
labour, premature rupture of membranes (more than 12 hours),fetal
distress due various causes ,cord compression and low apgar score, low
birth weight and prematurity.
Although blood cholesterol and lipid profile have been extensively
studied  in adults, limited studies are available in pediatric population,
more  so  in  our  country.  There  is  scanty  data  on  serum  lipid  levels  in
preterm and term newborns. This study was undertaken to find out the
influence of prematurity on cord lipid levels and to compare the cord
blood lipid levels in term and preterm newborns.12
Lipid profile is a marker of an underlying cardiovascular status.
Lipid profile includes measurement of cholesterol and its derivatives and
various atherogenic indices. Studies have shown that SGA babies had
abnormal lipid profile compared to AGA babies.8, 9, 10, 11,12
There are many studies showing the direct relationship between the
abnormalities in lipid profile among the SGA babies and occurrence of
cardiovascular diseases. The present study was undertaken for early
detection of abnormalities in the lipid profile at the earliest (at birth),
especially in the Preterm and SGA babies, so that these high risk babies
can be under vigilant monitoring in future.
Early diagnosis followed by prudent dietary supplementation and
drug therapy in these high risk neonates may provide an opportunity for
long range primary amelioration of risk factors that contribute to
development of cardio vascular diseases in adult life.
AIMS AND OBJECTIVES
1. To estimate and compare cord lipid profile (total cholesterol [TC],
triglyceride [TG], high density lipoprotein [HDL], low density
lipoprotein [LDL], (VLDL) (very low density lipoprotein) in
normal and low birth weight neonates.
2. Among low birth weight babies to estimate and compare cord lipid
profile (total cholesterol [TC], triglyceride [TG], high density
lipoprotein [HDL], low density lipoprotein [LDL], very low
density lipoprotein[VLDL]  in between  AGA and SGA neonates.
3. To estimate and compare cord lipid profile (total cholesterol [TC],
triglyceride [TG], high density lipoprotein [HDL], low density
lipoprotein [LDL], very low density lipoprotein[VLDL] in between
boy and girl neonates.
4. To estimate and compare cord lipid profile (total cholesterol [TC],
triglyceride [TG], high density lipoprotein [HDL], low density
lipoprotein [LDL], very low density lipoprotein[VLDL] in between
babies born  with primi and multi gravid mothers.
REVIEW OF LITERATURE
Daniel M. Lane et al. studied the various factors affecting the lipid
and apolipoprotein levels (A I, A II, C I, C II, C III, Apo B, Apo D and
Apo E) in cord sera and they collected data on cord sera levels from the
infants whose lipid metabolism might have been modified by a variety of
factors present before, at or after delivery. Method of delivery had a little
effect except in relation to either fetal immaturity (increased total
cholesterol) or fetal stress (increased triglycerides). Birth weight was
related to changes in free cholesterol, C I, CIII, and Apo E levels.
Gestational age had greater impact upon both serum lipids and
apolipoproteins, with increasing fetal maturity, total cholesterol, free
cholesterol, AII, C II, Apo E progressively decreased whereas
triglyceride and Apo D increased.13
P.K.Misra et al have observed a low mean triglyceride and Free
Fattyacids (FFA) levels in the cord blood of preterm (28 to 32 weeks)
neonates compared to term AGA neonates.14
N.Haridas, P.T.Acharya in a study of serum lipid status in neonates
carried out serial longitudinal determinations of serum triglycerides,
cholesterol, total lipids and lipoproteins in 60 each of normal full term,
preterm and low birth weight infants along with maternal triglyceride,
cholesterol and total lipid. They found that preterm and low birth weight
babies had higher cord blood triglyceride as compared to maternal levels.
Alpha lipoproteins constituted a higher percent of total lipoproteins in the
cord blood than in the mother’s blood. The cholesterol levels were not
significantly different in the three groups at birth.15
P P  Mathur  et  al  in  their  study  on  cord  blood  cholesterol  in  term
and preterm new born found a positive correlation between cord blood
cholesterol levels and gestational age, birth weight. Sex of babies did not
influence the cholesterol values.
A Kalra et al in their study on serum lipid profile in term and pre
term infants showed that total lipids, cholesterol, phospholipids, HDL
and LDL were lower in the cord blood of pre term babies as compared to
full term babies. But the difference was statistically significant only for
total lipids, cholesterol and phospholipids.17
J.Dogra et al studied the serum lipid profile of neonatal cord blood
in the families affected with diabetes mellitus type I, in 30 full term
neonates, and compared them with 30 control neonates without any
adverse factors. They found that neonatal triglyceride and cholesterol
were present in smaller proportions in cord serum than the maternal
serum at the time of parturition and they have different chemical identity
from the respective maternal lipids. The difference in serum cholesterol
levels in the study and control group was significant, while that of serum
triglycerides was insignificant.18
Ajay Kumar et al in their study demonstrated that cord blood.
Cholesterol levels are not influenced by birth weight and gestation, but
levels of cord blood triglyceride and FFA are affected by birth weight and
gestation.19
Y T Van-der schouw et al in their study of fatty acids composition
of serum lipids of mothers and their babies after normal and hypertensive
pregnancies suggested that neonatal Essential fatty acids (EFA) status
after pregnancy induced hypertension only slightly differs from normal.20
Kherkeulidze P et al in their study of HDL particle size distribution
in cord blood suggested that irrespective of sex, gestational age and birth
weight the newborns had 2 typical HDL subclass distributions,
characterized by high or low levels of HDL2b and HDL2a. The newborns
with high HDL2b and HDL2a levels also had low VLDL lipid levels and
high HDL cholesterol concentrations.21
MR Averna et al. studied the prevalence of hypercholesterolemia
in cord blood. Cholesterol, triglycerides, HDL cholesterol, apoprotein B
and LDL cholesterol in cord blood were assayed. 1275 term newborns
were  studied.  In  3.13%  of  them  cholesterol  levels  >mean  +  2  standard
deviations were present. Only 0.47% showed all three parameters levels
higher than mean + 2 standard deviations, and 0.31%, in spite of normal
cholesterol levels presented high LDL cholesterol and apo B levels. Thus
integrated utilization of these parameters in the neonatal screening of
familial hypercholesterolemia will have to be confirmed by follow up
studies.22
Xinli Wang et al. studied the Glucose and Lipid metabolism in
Small for gestational age infants at 72 Hours of Age, enrolling 296
singleton neonates (177 males and 119 females), including 76 classified
as  small  for  gestational  age  (SGA)  babies  (37  preterm and  39  full  term
newborns) and 220 appropriate for gestational age (AGA) babies (84
preterm and 136 full-term newborns) were included. Plasma glucose
levels were similar in the SGA and AGA groups, both for full-term and
preterm infants; however, insulin levels and insulin-to-glucose ratios
were significantly higher in the SGA group than in the AGA group. SGA
neonates had higher triglyceride, total cholesterol, and LDL-c levels than
did AGA infants both among full-term and preterm neonates (triglyceride
value 2.29 ± 0.23 vs. 1.57 ± 0.13 mmol/liter in full-term, P < 0.01; 2.27
±0.16 vs. 1.34 ± 0.11 mmol/liter in preterm, P< 0.01, total cholesterol
value 2.35 ±0.12 vs. 1.82 ± 0.22 mmol/liter in full-term, P=0.04; 2.57 ±
0.22 vs. 1.95 ± 0.15 mmol/liter in preterm, P =0.02, and LDL-c value
2.11 ± 0.58 vs. 1.24 ±0.61 mmol/ liter in full-term, P = 0.01; 1.87 ±
0.60 vs. 1.38 ±0.59 mmol/ liter in preterm, P< 0.01).23
MR Averna et al in their study suggested that
dehydroepiandrosterone sulfate measurements in cord blood do not give
any further information about transient neonatal hyper cholesterolemia.24
D  J  P  Barker  et  al.  in  their  study  ‘Growth  in  utero  and  serum
cholesterol concentrations in adult life’ found that, men and women who
had a small abdominal circumference at birth had raised serum
concentrations of low density lipoprotein, cholesterol and apolipoprotein
B. This was independent of the duration of gestation. The association
between abdominal circumference at birth and low density lipoprotein,
cholesterol concentration was independent of social class, bodyweight,
cigarette smoking, and alcohol consumption.25
Jagdish Singh et al. studied the cord Blood Cholesterol in Term
and Pre term Newborns, (100 newborns, term and preterm were 78 and
22, respectively. Seventy seven babies weighed >2.5 kg and 23 were of
<2.5 kg. Boys and girls were 56 and 44%, respectively). The mean cord
blood cholesterol (±1 SD) level was 90.4 ±18.2 mg/dl with a range of
51.4-126 mg/dl. In term babies, the mean level was 96.2 ±15.1 mg/dl as
compared to 69.5 ± 10.9 mg/dl in preterm (p <0.001). The mean levels
were 96.1 ± 15.0 and 66.8 ± 16.0 mg/dl in babies weighing >2.5 and <2.5
kg, respectively (p <0.001). Serum cholesterol values showed significant
positive correlation with gestational age and birth weight. 26
Jones J N et al. studied the cord serum lipid levels associated with
small for gestational age infants and found that, total cord serum lipid
content was markedly decreased in all SGA infants compared with AGA
infants (2.8 times lower).
Although SGA infants showed lower total lipid concentration,
SGA I and SGA II  infants  showed distinct  characteristics.  Infants  in the
SGA I group had higher triglyceride levels (1.8 times higher) and lower
free fatty acid levels (1.4 times lower), compared with AGA infants (P <
.001). The lipid subclass distribution in SGA II infants was not
significantly different from that in AGA infants, with the exception of an
increase in triglyceride concentrations (1.3 times higher). Although the
22-kD placenta derived apolipoprotein A-I was similar in all groups, the
level of fetal liver– derived 28-kD apolipoprotein A-I was 6.5 times
lower in SGA I infants than in AGA or SGA II infants (P < .001).9
 Molina  M  et  al.  in  their  study  “Lipid  profile  in  newborns  with
intrauterine growth retardation”, found that serum triglycerides levels
were higher in newborns with intrauterine growth retardation, compared
to (normal) term newborns.10
Claire L M et al. in their study ‘Long-term metabolic consequences
of being born small for gestational age’ found that, reduced fetal growth
is  independently associated with an increased risk of the development of
cardiovascular diseases, the insulin-resistance syndrome, or one of its
components: hypertension, dyslipidemia, impaired glucose tolerance, or
type 2 diabetes.
All  of  them  appear  to  result  from  the  initial  development  of
insulin-resistance which appears as a key component underlying the
metabolic complications. Although the mechanism remains unclear, there
is  some  evidence  that  argues  in  favor  of  an  active  contribution  of  the
adipose tissue in the emergence of insulin-resistance associated with in
utero under nutrition.27
B  Geloneze  et  al.  in  a  study  titled  ‘Atherogenic  lipid  profile  of
Brazalian near term newborns’ in 2005 divided the cord blood of 135
newborns (66 males), into two groups: 25 near-term neonates (35-36
weeks of gestational age) and 110 term neonates (37-42 weeks of
gestational age). The total cholesterol concentrations were higher in the
near-term neonates than in the term group (94.04 ± 8.02 vs. 70.42 ± 1.63
mg/dl, P < 0.01), due to an increase in the LDL-cholesterol fraction in the
near-term group (57.76 ± 6.39 vs. 34.38 ± 1.29 mg/dl, P<0.001). The
atherogenic indexes (total cholesterol/HDL-cholesterol, LDL
cholesterol/HDL-cholesterol and apolipoprotein B/apolipoprotein A-I)
were higher in the near term group (P < 0.001, P < 0.001, and P< 0.05,
respectively).
The gestational age of the newborns was inversely correlated with
total cholesterol and LDL-cholesterol, and also with the total
cholesterol/HDL- cholesterol and LDL-cholesterol/ HDL-cholesterol
indexes.11
Jane Oba et al conducted a study on 212 neonates out of them 107
was females and 105 were males. They found serum concentrations of
total cholesterol, LDL and HDL cholesterol were higher in preterm then
term newborns but triglyceride values were lower in preterm than term
newborn. They also found that SGA newborns have higher levels of
triglycerides, total cholesterol, HDL and LDL cholesterol compared to
AGA.28
Hossain MA et al. measured the Serum triglyceride level in IUGR
babies and they compared it with preterm AGA and term normal babies.
Serum TG levels were estimated among three groups: IUGR (n=30),
preterm appropriate for gestational age (AGA) (n=30) and term normal
(n=30) new born babies. It was observed that serum TG level (54.4 ±
11.2 mg/dl) in IUGR babies were significantly higher than that of term
normal babies (38.7 ± 5.8 mg/dl), p value < 0.05.12
 Roya Kelishadia et al. showed that among 442 (218 boys and 224
girls) normal vaginal delivery newborns,14.4% were preterm and rest
were full term, around 9.2% (n = 35) of the full-term newborns were
small-for-gestational-age (SGA), of which 16 had a Ponderal index (PI)
below the 10th percentile (SGA I) and 19 had above the 10th percentile
(SGA II), 5.5% (n = 21) were large-for-gestational-age (LGA), and the
remainder were appropriate-for-gestational-age (AGA).
Total and high-density lipoprotein cholesterol (HDL-C) in girls
were significantly higher than in boys (80.3 ± 33.3 and 31.1 ± 9.9 vs.
73.3 ± 23.1 and 28.8 ± 8.7 mg/dL, respectively, P < 0.05). The mean
apolipoprotein A (APO-A) of neonates with underweight mothers was
significantly lower, and the mean APO-B level of those with overweight
mothers was significantly higher than other neonates.
The mean low-density lipoprotein cholesterol (LDL-C), HDL-C
and APO-A of the LGA newborns were significantly lower, and their
APO-B was significantly higher compared to AGA and SGA neonates.
The SGA I neonates had significantly lower total cholesterol, LDL-C,
HDL-C and APO-A, as well as higher triglycerides, lipoprotein-A and
APO-B than the SGA II group. The mean cord blood triglycerides of full-
term neonates was significantly higher than preterm neonates (69.4 ±11.9
vs. 61.4 ± 12.7 mg/dl, respectively, P = 0.04).29
Cristina Catarino et al. studied the impact of maternal lipid changes
upon the fetus in pre-eclampsia by evaluating lipid profile simultaneously
in maternal and umbilical cord blood. Forty-two healthy pregnancies and
46 pregnancies complicated with pre-eclampsia were taken. Total
cholesterol (TChol), HDL- cholesterol (HDLc), LDL-cholesterol (LDLc)
and triglycerides (TG) levels were determined using enzymatic methods.
Apolipoprotein (APO) A I, APO-B and lipoprotein (a) [Lp(a)]
values were measured by immunoturbidimetry. They found that Pre-
eclamptic women presented significantly higher values for TChol, LDLc,
HDLc, TG, APO-AI and APO-B compared to normal pregnant women.
In the cord blood from pre-eclamptic pregnancies, significantly lower
values for HDLc and APO A-I, and significantly higher TG
concentrations and LDLc/HDLc ratio were observed when compared to
normal cases. A positive correlation was observed between maternal TG
levels and proteinuria, a marker of pre-eclampsia severity (r =0.40,
p<0.01).
Their data suggested that pre-eclamptic pregnancy is associated
with an enhanced hyperlipidemia, which seems to have a negative impact
on fetal lipid profile, as reflected by a higher atherogenic LDLc/HDLc
ratio and higher TG levels in cord blood. These children, born of women
with PE, may deserve a closer clinical follow-up later in life.30
Badiee Z et al. cord lipid profile, apolipoprotein A, apolipoprotein
B and lipoprotein a (LPa) were analysed in 378 full term newborns.
Female neonates had significantly higher concentrations of TC and HDL-
C than male neonates 81.4±28.3 Vs. 75.2±21.1, P=0.02 and 31.18±9.97
Vs. 28.8±8.7, P=0.0.02respectively. Other biochemical factors were not
significantly different between gender.31
BIOCHEMISTRY OF LIPIDS
Lipids constitute a very important group of organic substances in
animal  tissues.  The  term  LIPID  was  suggested  by  BLOOR  and
recommended by International union of Pure and Applied Chemistry.
According to Bloor,32 Lipids are compounds having the following
characteristics:
1. Insolubility in water and solubility in one or more organic solvents
 (eg. Ether, Chloroform, Benzene, Acetone-the so called fat
 solvents)
2. Some relation to fatty acids and ether, either actual or potential.
3. Possibility of utilization by living organism
THE FOLLOWING CLASSIFICATION OF LIPIDS IS
MODIFIED FROM BLOOR: 33,34
SIMPLE LIPIDS
Esters of fatty acids with various alcohol.
a. FATS:Esters of fatty acids with glycerol. A fat in liquid state is
known as oil.
b. b.WAXES: Esters of fatty acids with higher molecular weight
monohydric alcohol.
COMPLEX LIPIDS
Esters of fatty acids with various alcohol and fatty acid.
a. PHOSPHOLIPIDS: Lipids containing, in addition to an alcohol, a
phosphoric acid residue. They frequently have nitrogen containing
bases and other substituents, eg. In glycerophospholipids the alcohol
is glycerol and in sphingophospholipids, the alcohol is sphingosine.
b. GLYCOLIPIDS (GLYCOSPHINGOLIPIDS:Lipids containing a
fatty acid, sphingosine and carbohydrate.
c.  OTHER  COMPLEX  DISEASE:  Lipids  such  as  sulfolipids  and
amino lipids.
Lipoproteins may also be placed in this category.
Plasma lipids consist of triacylglycerols (16%), phospholipids
(30%), cholesterol (14%), and cholesteryl esters (36%) and a much
smaller fraction of unesterified long- chain fatty acids (free fatty acids)
(4%). This latter fraction, the free fatty acids (FFA), is metabolically the
most active of the plasma lipids.
PRECURSOR AND DERIVED LIPIDS: These include fatty acids,
glycerol, steroids, alcohols in addition to glycerol and sterols, fatty
aldehydes and ketone bodies, hydrocarbons, lipid soluble vitamins and
hormones. Because they are uncharged acylglycerols (glycerides),
cholesterol and cholestryl esters are termed neutral lipids.
FREE FATTYACIDS
Fatty acids are transported from their storage site in adipose tissue
to their site of utilization as triglycerides and the rate limiting enzyme in
this mobilization is a hormone sensitive lipase. Free fatty acids undergo
oxidation re-esterification or conversion to other fatty acids. The major
sites of oxidation are liver and heart in resting state and skeletal muscles
during exercise. Fatty acids are taken up by liver are re-esterified to
triglycerides and phospholipids. Normal mean plasma level is
12mg/100ml.
TRIGLYCERIDES
Triglycerides consists of glycerol esterified with three long chain
fatty acids such as stearic (18 carbon atoms) and palmitic acid(16 carbon
atoms).These together with fatty acids are saturated, certain unsaturated
fatty acids are important as precursors of prostaglandins and in the
esterification of cholesterol .Both saturated and unsaturated fatty acids
are important components of cell membrane.
In general vegetable oils are triglycerides that are liquid at room
temperature due to their higher unsaturated or shorter length carbon chain
fatty acids. Triglycerides are the most abundant naturally occurring
lipids. The type formula of fat or oil is as follows: Usually R1 and R2 are
saturated fatty acids and R2 is unsaturated fatty acid. Since all three of
the glycerol alcohol groups are esterified, these fats are termed as
triglycerides.
The chief source of dietary fats is obtained endogenously from
liver and small intestine. Dietary triglycerides have relatively short half
life in plasma and are removed mostly by adipose tissue, thus the
measurements of fasting sample reflects the amounts of endogenous
triglycerides.
CHOLESTEROL: 34,35
It is a sterol possessing a four ringed steroid nucleus and a
hydroxyl group. It occurs in both free and esterified forms. Free
cholesterol is a component of all cell membranes. The esterified form
predominates in adrenal cortex, plasma and athermanous plaques. Under
normal circumstances, virtually all the newly synthesized cholesterol
originates from the liver and distal part of small intestine. Fecal excretion
in the form of natural esterol and bile acids about 1gm/day, balances the
synthesis and absorption. In childhood, normal values vary from 42-
205mg/dl.
FIGURE 1: STRUCTURE OF CHOLESTEROL34
LIPOPROTEINS: 34,35
Lipoproteins are proteins conjugated to a lipid like lecithin,
cephalin, and neutral fat. These are globular particles of very high
molecular weight that transport non polar lipids (triglycerides and
cholesterol) in the circulation to liver and peripheral tissues.
Since lipids are insoluble in water, the problem of how to transport
them in the aqueous blood plasma is solved by associating nonpolar
lipids (triacylglycerol and cholesteryl esters) with amphipathic lipids
(phospholipids and cholesterol) and proteins to make water miscible
lipoproteins.
In addition to FFA, four major groups of lipoproteins have been
identified that are important physiologically and in clinical diagnosis.
These are
a) Chylomicrons derived from intestinal absorption of
triacylglycerol and other lipids;
b) Very Low Density lipoproteins (VLDL, or pre-?-lipoproteins),
derived from the liver for the export of triacylglycerol;
c) Low-Density lipoproteins (LDL, or ?- lipoproteins), representing
a final stage in the catabolism of VLDL; and
d) High-Density lipoproteins (HDL, or ?-lipoproteins), involved in
VLDL and chylomicron metabolism and also in cholesterol transport.
FIGURE 2: THE DENSITY OF THE SEVERAL CLASSES OF
LIPOPROTEIN IS INVERSELY PROPORTIONAL TO THE
RATIO OF LIPID TO PROTEIN
Lipoproteins function both to keep their component lipids soluble
as  they  transport  them  in  the  plasma,  and  also  to  provide  an  efficient
mechanism for transporting their lipid contents to (and from) the tissues.
Lipoproteins mediate this cycle by transporting lipids from the
intestines as chylomicrons and from the liver as very low density
lipoproteins (VLDL) to most tissues for oxidation and to adipose tissue
for storage.
Triacylglycerol is the predominant lipid in chylomicrons and
VLDL, whereas cholesterol and phospholipids are the predominant lipids
in LDL and HDL, respectively Lipoproteins may be separated according
to their electrophoretic properties into ?, ?, and pre ?-lipoproteins.
The constituents of these  macro  molecular  complexes  includes
triglycerides, cholesterol, phospholipids and apolipoproteins. Each
complex particle contains a nonpolar core mostly triglycerides and
cholesterol in varying proportions with a polar surface coat of
phospholipids, so that it can remain in solution in plasma. Plasma
lipoproteins differ according to the flotation rate, hydrated density, size
and electrophoretic mobility.
STRUCTURE OF A PLASMA LIPOPROTEIN:34,35
The nonpolar lipid core consists of mainly triacylglycerol and
cholesteryl ester and is surrounded by a single surface layer of
amphipathic phospholipid and cholesterol molecules. These are oriented
so that their polar groups face outward to the aqueous medium, as in the
cell  membrane.  The  protein  moiety  of  a  lipoprotein  is  known  as  an
apolipoprotein or apoprotein, constituting nearly 70% of some HDL and
as little as 1% of chylomicrons.
The plasma lipoproteins are spherical macromolecular complexes
of lipids and specific proteins (apolipoproteins or apoproteins). They
differ in lipid and protein composition, size, and density.
FIGURE 3: STRUCTURE OF A PLASMA LIPOPROTEIN35
Figure 4: Structure of a Plasma Lipoprotein
Apoproteins are the protein moiety of lipoproteins.34,35
They have three main functions:-
1) They regulate the reactions of these lipids with enzymes.
2) They help solubililize cholesterol esters and triglycerides.
3) They bind to cell surface receptors and thus determine the sites of
uptake and rates of degradation of other constituents especially
cholesterol.
Are also Constituent proteins. They are responsible for a variety of
metabolic functions in addition to their structural role, including cofactors
or inhibitors of enzymatic pathways, and mediators of lipoprotein binding
to cell surface receptors. ApoA is the major apoliprotein of HDL. ApoB
is present in LDL, VLDL, IDL, and chylomicrons. ApoB-100 is derived
from the liver, whereas apoB-48 comes from the small intestine. ApoC-I,
C-II, and C-III are small peptides important in triglyceride metabolism.
Likewise, apoE, which is present in VLDL, HDL, chylomicrons, and
chylomicron remnants, plays an important role in the clearance of
triglycerides.
High levels of VLDL and LDL in serum indicate that the
individual is at risk with regard to protective effect against the
development of atherosclerosis. Normal plasma LDL and VLDL levels in
childhood vary in childhood varies from 63-136 mg/dl.
High levels of VLDL and LDL in serum indicate that the
individual is at risk with regard to protective effect against the
development of atherosclerosis. Normal plasma LDL and VLDL levels in
childhood varies from 63-136mg/dl and 4-24mg/dl respectively.
LIPID AND SEX VARIATION:36,37
No statistically significant difference in the levels of lipids was
found in boys and girls in the same age group till puberty. HDL levels
decline in both during puberty. In girls the HDL level subsequently
increases to the pre pubertal concentration. In boys the level remains low
after puberty. Males have higher LDL cholesterol but low HDL
cholesterol than females .The lower incidence of coronary heart disease
in women could be related to their persistently higher HDL concentration
than males or lower LDL levels. This finally establishes the different
lipoprotein patterns seen in adults.
FAMILIAL INFLUENCES AND AGGREGATION
The incidence of coronary artery diseases reached epidemic
proportion in most developed countries and is gradually rising in
developing countries.39 Of all coronary risk factors the importance of
hyperlipoprotenemia and hyperlipidaemia looms large. At least 3
lipoprotein disorders of familial type viz, type 2, 3 and 4 are known to
accelerate atherosclerotic changes and hence premature coronary artery
disease.40 Except for type 2 hypertriglyceridemia where inheritance
pattern is by a single gene defect, most of other triglyceridemia show
multi-factorial inheritance. A study by Krishna Kumar et al.41 on “Serum
Lipid Profile in children of parents with coronary artery diseases” showed
that Coronary Artery disease is a striking at more and more younger
subjects. Hyperlipidaemia and hyperlipoproteinemia are associated with
premature atherosclerosis and children of coronary artery diseases
patients are at greater risk to develop coronary artery diseases as these
lipid abnormalities are genetically transmitted.
Neonatal familial type 2 hyperlipoprotenemia may often be
identified by elevated levels of cord blood cholesterol and LDL
cholesterol.42 A study by J. Dogra et al.43 on the serum lipids in neonatal
cord blood in families with diabetes mellitus type-1 suggests the role of
genetic factors in transmission of hypercholesterolemia in families
affected with diabetes mellitus type-1.Thus a periodic surveillance of
neonates belonging to these families can benefit in an earlier detection of
atherosclerosis.
R.C.Tsang  et  al.44 in  their  study  of  cholesterol  at  birth  and  at  the
age of one year recommended that hypercholesterolemia can be
diagnosed by estimation of cord blood cholesterol and LDL cholesterol.
A study by T.J.C Boultan33 comparing the relative influence on the
children total cholesterol of nutritional and a family history of early
coronary heart diseases were found to be important correlates of the
children’s total cholesterol level become increasing important from the
end  of  the  1st year ,or that the effect of these influences is obscured
during infancy by other ,presumably nutritional factors, which themselves
are elusive because of the inherently inadequate methodological
techniques of dietary studies.
CORD BLOOD LIPID PROFILE AND NEONATES:42
Neonatal familial type-2 hyperlipoprotenemia may often be
identified by elevated levels of cord blood cholestrol and LDL
cholesterol.
A  study  by  Reginald  Tsang  et  al  on  cord  blood
hypertriglyceridemia, was originally designed to assess the utility of cord
blood cholesterol analysis in the diagnosis of neonatal and familial type-2
hyperlipoprotenemia. The data suggested that hypertriglyceridemia at
birth is an indicator or ante partum fetal stress or compromise. It is
possible that quantization of cord blood triglyceride might provide a
rapid, easily available, and in expensive measure that could be used
prospectively or retrospectively in analysis of ante partum or intra partum
factors that adversely affect the fetus.
SERUM LIPIDS AND DIET:43,44,45,46
In a study by T.J.C.Boultan,33 serum cholesterol in early childhood,
comparing the relative influence on the children’s total cholesterol of
nutritional and familial factors, the parent’s total cholesterol and family
history of early coronary heart disease were found to be important
correlates of the children’s total cholesterol. Low correlations occurred
for nutritional factors. While comparing the breast fed and formula fed
infants, a number of workers have found significant effects directly
depending upon polyunsaturated fatty acids and cholesterol content of
the formula.
Familial hypercholesterolemics on moderate to high cholesterol
intake at one year maintain distinctive elevation while low cholesterol
diet reduces the differences between index and controls.
There is much inter individual variations in response to dietary
fats. The great differences in the plasma cholesterol in various countries
are also related to difference in dietary habits. The saturated fatty acids
definitely raise the total cholesterol levels while polyunsaturated fatty
acids have cholesterol lowering action. Monounsaturated fatty acids have
no effect i.e. are neutral. Dietary cholesterol increases the serum
cholesterol levels possibly by suppressing the hepatic LDL receptors.
Carbohydrates and fibers also affect the metabolism of
lipoproteins. Increased intake stimulates the hepatic synthesis of
triglycerides and can increase LDL levels and decrease HDL cholesterol
levels.
LIPID PROFILE AND TERM NEONATES:
Several studies have revealed that the concentration of total
cholesterol, VLDL+LDL cholesterol and triglyceride are low compared
to adults and have wide range. Nearly 50% of total cholesterol and 30%
of total triglyceride is present in HDL constitutes a higher percentage of
total lipoproteins as compared to adults.45
LIPID PROFILE AND PRETERM AND LOW BIRTH WEIGHT
BABIES:
The preterm and low birth weight new born have higher cord blood
triglycerides as compared to normal full term newborns according to a
study on serum lipid status in neonates by N.Haridas, P.T.Acharya.45 In
low birth weight infants this could be indicative of intrauterine
malnutrition and starvation. But no difference was found in respect of
cholesterol level in the cord blood. The vast difference between cord
blood and maternal lipids reveal the possible lack of maternal
contribution of fetal lipids.
The Low Birth Weight Infants are born with intrauterine
malnutrition. Such circumstances favour fetal adipose tissue breakdown
liberating free fatty acids .That portion of free fatty acids that escapes
oxidation for energy is synthesized in liver into triglycerides which cause
elevated levels of triglycerides in low birth weight as compared to normal
full term infants. Intrauterine malnutrition resembling marasmus and
starvation in other children could be the result of placental insufficiency.
The normal full term ones on the contrary are in receipt of a ready
placental supply of nutrients, and so there is very little need for
lipolysis in utero.26 While contrary findings were reported by
P.K.Mishra et al.46
Higher free fatty acids and triglyceride levels in the cord blood of
SGA neonates may be due to release of free fatty acids from fat stores for
energy metabolism in presence of intrauterine malnutrition. In the
intermediate postnatal period lower level of free fatty acids in these
newborn compared to control may be result of relative depletion of fat
stores by the intrauterine release. The high levels of triglycerides in the
fasting state may be as a result of very high triglyceride levels in the cord
blood. The lesser rise in the free fatty acids levels in preterm AGA of 28-
32weeks gestation may be as a result of insufficient lipid stores and
lipolysis in them.46
LIPIDS AND ATHEROSCLEROSIS:
The clinical interest in serum lipids, lipoproteins and
apolipoproteins is related almost exclusively to their relationship to
atherosclerosis. In recent times considerable epidemiological evidence
has accumulated in support of a strong association between raised
cholesterol concentration and subsequent risk to the development of the
coronary artery disease. Furthermore number of investigators, now
considers only LDL and high density lipoproteins worthy of
consideration as major risk factors in the development and progression of
atherosclerotic vascular disease.47,48
The American Heart Association and National Heart, Lung and
Blood Institute in a joint statement has presented overwhelming evidence
to support the continuous and positive correlation of coronary artery
disease with blood cholesterol level .One percent reduction in an
individual total cholesterol translates into approximately two percent
reduction in coronary artery risk.
Low serum cholesterol levels are accompanied by prolongation of
life and improvement in the quality of life and is ever beneficial for
people who already had coronary heart disease.49
George Steiner bet al.49 in  their  study  of  “The  association  of
increased levels of intermediate density lipoproteins with smoking and
with coronary artery disease” showed that HDL cholesterol was
somewhat reduced in those with coronary artery disease. The possible
importance of HDL lies in the demonstration of a “protective” effect of
this lipoprotein in relation to coronary artery disease and the frequent, but
not invariable, inverse relationship between HDL and plasma triglyceride
levels. Because of its importance in triglyceride transport, they paid
particular attention to the levels of intermediate density lipoproteins. The
association of LDL with documented coronary artery disease may be
important in consideration of the relationship of hypertriglyceridemia to
atherosclerosis, particularly in view of large proportion of triglyceride-
rich lipoproteins found in LDL.
Increased concentration of LDL have been reported in patients
with renal failure, type -3 hyperlipoproteinemia and possibly diabetes,
and may contribute to the accelerated atherosclerosis observed in these
patients.  Their  study  pointed  out  the  association  of  LDL  with
atherosclerosis.
The protective role of HDL cholesterol has been well established
by a number of workers. Elevated HDL cholesterol is antiatherogenic and
a low level is an independent risk factor for coronary artery disease.
Since HDL cholesterol participates in reverse transport of cholesterol it
reduces the accumulation of cholesterol in arterial wall or prevents the
formation of thrombi on atheromatous plaques by stabilization of
prostacyclines.
THE CHILD AND ATHEROSCLEROSIS:
Connar  S  L  et  al.37 in their study found that the mean cholesterol
concentration in males were higher in childhood and lower at post
puberty. Thereafter, it generally increased with age, attaining a maximum
mean concentration at age 55-60 years. The mean plasma LDL
cholesterol concentrations paralleled the age related increase in the total
plasma cholesterol. A general drop in the HDL cholesterol levels
occurred through childhood and early adulthood, followed by an increase
with age in females and no increase in males.
In children, the correlation coefficients were strikingly different
from  those  in  adults.  The  total  cholesterol,  LDL  and  HDL  did  not
correlate with age or adiposity. As in adults, however the plasma
triglyceride correlated with age, weight and adiposity. Plasma
cholesterol, LDL cholesterol and triglyceride, remained positively
correlated with age after adjusting for weight. Similarly the plasma
triglyceride remained correlated with weight after adjusting for age.
The fatty streaks appear in coronary arteries at about the age of 15
years and these were found to be significantly related to levels of total
cholesterol, VLDL cholesterol and systolic blood pressure. The fate of
fatty  streaks  is  not  well  established  but  animal  studies  suggest  that  they
may remain unchanged, disappear or ultimately develop into
athermanous plaque. The presence of fatty streaks in arteries of new born
and children implies that preventive measures should be instituted early
in life, before these streaks transforms into adult atheromas. Early
prevention becomes more important in childhood as good dietary habits
are also formed during this period which has a bearing upon serum
lipids.50,51,52
LIPID PROFILE AND SGA NEONATES:
Levels of lipids and lipoproteins in cord sera should be a reflection
of the status of plasma lipid metabolism in the infant at birth. Most fetal
lipids are synthesized de novo through the conversion of glucose to
various fatty acids- containing compounds. Where as part of lipids are
obtained from the maternal circulation by the placenta principally in form
free fatty acids and cholesterol, and this transfer increases as the
gestational age advances, and this deposition is more in the last
trimester.53
It is known that premature newborns including SGA babies have
lost the chance to complete their energy deposits because of preterm
delivery. Thus, many times the preterm neonate needs to use these
endogenous reserves, basically activating lipid metabolism that generates
energy and promotes gluconeogenesis, where by altering lipid
metabolism in this high risk babies.54
The lipid profile of the SGA group indicated markedly diminished
fetal liver– derived apolipoprotein A-I levels and decreased absolute total
lipid levels; however, at relative concentrations, triglycerides were
elevated and free fatty acids lowered. Those alterations are consistent
with an inability to hydrolyze circulating triglycerides, because of
decreased activity of lipoprotein lipase enzyme, leading to diminished
peripheral adipose deposition. The lower free fatty acid levels in the
absence of adequate peripheral adipose deposition might be consistent
with depletion, secondary to use as an alternate fuel source or might be
simply a reflection of a more severe degree of uteroplacental
insufficiency in that group.55
The underlying mechanism linking SGA with adverse lipid levels
is not well understood. It is generally assumed that factors influencing
insulin sensitivity may explain the association between birth weight and
dyslipidemia.56
Hyperinsulinemia is known to enhance hepatic very-low-density
lipoprotein synthesis, which may contribute to increased plasma
triglycerides and LDL-c levels. Resistance to the action of insulin on
lipoprotein lipase in peripheral tissues may also contribute to elevated
triglyceride and LDL-c levels.56
Other mechanism includes decrease in the activity of the lectin
acetyl cholesterol transferase (L CAT) enzyme; the fall in HDL-
cholesterol levels may be associated with a decrease in the activity of the
lectin acetyl cholesterol transferase enzyme. Studies have demonstrated
that lectin acetyl cholesterol transferase activity is lower in near term
neonates (SGA) compared with the term infants.56
Even the concentrations of apolipoprotein A-I and apolipoprotein
B were significantly different in near term babies (SGA), many studies
have  shown  that  a  trend  towards  a  worse  lipid  profile  in  the  near-term
group (SGA), with higher apolipoprotein B levels, related to low-density
lipoproteins, and lower apolipoprotein A-I levels, related to the inverse
cholesterol transport, that protect against atherosclerotic lesions.
Moreover the apolipoprotein B/apolipoprotein AI index, considered to be
one of the best markers of risk for cardiovascular disease even during the
first year of life, was significantly higher in the near-term neonate group
compared with the term group, demonstrating that this index is altered
even in umbilical cord blood…
Many studies have demonstrated that total cholesterol, LDL-
cholesterol fraction and atherogenic indexes are significantly higher in
near term neonates compared with term infants, showing a trend to a
worse lipid profile in near-term infants. Future studies are needed to
determine if this atherogenic profile in near-term neonates can affect
body metabolism, increasing the risk for cardiovascular diseases in adult
life.
FETAL LIPOGENESIS:34
The three principle pathways of fatty acid synthesis are:
1. De novo synthesis in the cytosol of the cell.
2. Fattyacids chain elongation by microsomes.
3. Fattyacids chain elongation by mitochondria.
De novo synthesis of long chain fatty acids from acetyl coenzyme A
(COA) is the primary synthetic pathway in most cells.
The net reaction involved in denovo synthesis of fatty acids, using
palmityl COA as an example, is
8Acetyl-COA+14NADPH+14H?+FATP+H2O?Palmitic
acid+8COA+14NADP+FADP+FPI
De novo synthesis of fatty acids requires a series of enzyme
controlled reactions. The initial reaction of de novo synthesis, the
carboxylation of acetyl COA to form malonyl COA, is catalyzed by the
enzyme acetyl COA carboxylase. This enzyme is thought to be the rate
limiting enzyme for fatty acids synthesis. In the subsequent series of
reactions, the fatty acids synthetase complex catalyses the synthesis of 1
mole of palmitic acid from 7 moles of malonyl COA and 1mole of acetyl
COA,ATP and NADPH provide the energy required for this complex
series of reaction.
Long chain fatty acids are synthesized by the chain elongation of
preexisting fatty acids. In mitochondria, the reversal of ?-oxidation with
the resulting incorporation of acetyl COA into pre existing fatty acids
results in fatty acids chain elongation by the sequential addition of two
carbon subunits. The microsomal and mitochondrial elongation pathways
play a relatively minor role in fatty acids synthesis compared to de novo
synthesis .One possible exception is in the heart where mitochondrial
chain elongation is the only pathway for long chain fatty acids synthesis.
PRECURSORS OF FETAL LIPOGENESIS:34,35
Carbohydrates in the form of glycogen, glucose and lactate have
been reported to be the major precursors for de novo synthesis of fatty
acids in the fetus and neonate. Nearly 40%of all maternal glucose that is
perfused into the placenta is metabolized to lactate by the placenta. One
possible reason for the preferences of the lactate to glucose as a precursor
for lipogenesis is that lactate exists in a high redox state.
Conversion of lactate to pyruvate results in the conversion of NAD
to NADH. Lactate may indirectly provide the NADPH required for de
novo synthesis of fatty acids. Determination of the presence of
transhydrogenases in these fetal tissues in which de novo synthesis of
fatty acids occurs (eg.Lung, Liver and adipocytes) would support this
theory.
Glucose, amino acids and ketone bodies have been investigated as
precursors for lipid synthesis. Amino acid was found to be a minor
precursor for fetal adipose tissue lipogenesis.
To determine if substrate availability of glucose controls fetal
lipogenesis in vivo Ktorza et al induced mild hyperglycemia in
unrestrained pregnant rats at 20.5-23.5 days of pregnancy by infusing
glucose. They reported that total carcass fat of the fetus is increased over
control levels and that the rate of lipogenesis is significantly greater in the
hyperglycemic fetuses, suggesting that substrate availability of glucose
does control fetal lipogenesis.
THE BARKER HYPOTHESIS:
David Barker M.D.64 Ph.D.  FRS  is  a  Physician  and  Professor  of
Clinical  Epidemiology  at  the  University  of  Southampton,  UK  and
Professor in the Department of Cardiovascular Medicine at the Oregon
Health and Science University, US. Twenty years ago, he showed for the
first  time  that  people  who  had  low  birth  weight  are  at  greater  risk  of
developing coronary heart disease. In 1995, the British Medical Journal
named this the “Barker Hypothesis.” and is now widely accepted. 64
The observation that deaths from ischemic heart disease appeared
linked to birthplace led to the suggestion that pre-natal and early post-
natal factors may be risk factors for ischemic heart disease. This
hypothesis was first formally tested  by  Barker et al.64,65 who examined
the mortality records of 5654 men born during 1911– 1930 in
Hertfordshire, England. This study showed that men with the lowest
weights at birth subsequently had the  highest  death  rates  from
ischemic  heart  disease.  This association between coronary heart disease
and small size at birth has now been replicated in a number of studies in
Europe,66,67 North America68 and India.69
As a consequence of these findings, Barker64,70 proposed the
concept of a ‘fetal origin of coronary heart disease’. In essence this model
proposes that in response to under nourishment; the fetus undergoes a
number of physiological and metabolic adaptations. These adaptations
persist post-natally and predispose the individual to coronary heart
disease in later life. Since the original formulation of this hypothesis,
further work has led to a number of refinements in this theory.
There  is  now growing  awareness  that  the  long-term  effects  of
intrauterine under nutrition  depend  upon  its  timing  during  gestation.
Retrospective analyses of babies born during the Dutch famine of 1945
have shown an association between CHD and early (as opposed to late)
nutritional challenges during gestation.71
Similarly, there is increasing evidence of the importance of not
only the pre-natal environment, but also the early post-natal environment
as a determinant of cardiac disease. Eriksson et al.72 have recently shown
an association between CHD and rapid childhood weight gain, and this
finding has now been replicated in other studies. Napoli et al.73 Have
shown that maternal hypercholesterolemia during pregnancy induces
changes    in    the    fetal    aorta    that     determine     the     long-  term
susceptibility of children to subsequent atherosclerosis.
Dr.  Barker’s  work  is  relevant  to  both  Western  countries  and  the
Third World. In the Western world, many babies remain poorly nourished
because their mothers eat diets that are unbalanced in macronutrients and
deficient in micronutrients, or because their mothers are excessively thin
or overweight. In the Third World, many girls and young women are
chronically malnourished.
Coronary heart disease (CHD), hypertension, and diabetes mellitus
(DM) occur in epidemic proportions worldwide. Unhealthy lifestyle
practices and behaviors are well accepted as contributing factors, but the
true origins of these diseases may actually be found in utero.
Finally, according to the Barker hypothesis, disturbed intrauterine
growth has a negative influence on the development of the cardiovascular
system and favors the occurrence of hypertension, insulin resistance,
Diabetes mellitus, hypercholesterolemia, and hyperuricemia in adult
life.64
MATERIALS AND METHODS
STUDY DESIGN: This is a Cross – sectional Hospital based study.
SOURCE OF DATA:
This  study  was  conducted  at  GOVT  KILPAUK  MEDICAL
COLLEGE HOSPITAL during the term between MARCH 2018 TO
AUGUST 2018.
Study subjects included 100 babies in which 50 babies had birth
weight above 2.5 kg and 50 babies had birth weight below 2.5 kg..
INCLUSION CRITERIA:
Term babies with birth weight more than 2.5 kg
(GROUP A)
Preterm babies with birth weight less than 2.5kg
(GROUP B)
EXCLUSION CRITERIA:
1) Neonates with any Congenital malformations.
2) Neonates born to mother with maternal illness like Diabetes
mellitus (DM) including Insulin dependent diabetes mellitus
(IDDM) & gestational diabetes, Tuberculosis, Asthma, Pregnancy
induced hypertension, thyroid disease.
3) Neonates with family history of coronary heart disease /
hypercholesterolemia.
4) Any maternal medication, except iron & vitamin supplements.
5) Drug abuse in mother and antenatal medications
6) Instrumental delivery including extraction
7) Neonates with one minute Apgar score <7 at 5min
METHOD OF THE STUDY:
This hospital based prospective study was carried out at NICU unit
at GOVT KILPAUK MEDICAL COLLEGE CHENNAI 10 from
MARCH 2018 to AUGUST 2018. Newborn babies delivered  during this
period who fulfilled the inclusion criteria were enrolled in this study.
All the subjects were included after obtaining written informed
consent from parents/ guardian.
5 ml of cord blood was collected from the umbilical cord
immediately after the delivery from the placental end of the cord just
after  the  delivery  of  the  baby  in  a  plain  dry  test  tube.  Cord  blood  was
allowed to clot and then immediately sent to lab where the samples were
centrifuged at 400×for 10 minutes, and then serum was separated and
stored at -20 0C until analysis.
After the delivery, the babies were examined, weight was recorded
on electronic weighing scale, length was recorded with the help of
infantometer, head circumference, chest circumference and other relevant
anthropometric data were recorded using non stretchable measuring tape.
Gestational age was calculated from the first day of the last menstrual
period and confirmed by clinical assessment using modified New
Ballard’s score.
A thorough clinical examination of the newborn was done and
weight of the baby was calculated by electronic weighing scale.
Classification of infants was done based on gestational age as term and
preterm newborn based on New Ballard’s scoring.
Babies  were  classified  as  AGA  and  SGA  with  the  help  of
intrauterine growth charts. Intrauterine growth charts developed at
AIIMS were used to assess the weight for gestational age.
Lipid profile was done by using Auto analyser (Erba Mannheim,
Transasia bio-medical LTD). TC estimated by using Modified Roeschlau
method, TG estimated by using Wako and the modification by McGowan
et al. and Fossati et al. HDL and LDL estimated based on a modified
polyvinyl sulfonic acid (PSV) and polyethylene- glycol methyl ether
(PEGME) coupled classic precipitation method with the improvements in
using optimized quantities of PSV/PEGME and selected detergents.
VLDL estimated by TC/5 and Atherogenic index (AI) by TC/HDL.
STATISTICAL ANALYSIS
Results were expressed as mean ± standard deviation for
continuous variables and as number and proportion (%) for categorical
data. Since all data are known to be normally distributed, the parametric
tests were used for statistical analyses. Differences between  normal birth
weight and low birth weight and SGA, AGA neonates as well as between
male and female neonates were determined by Student’s t test.
Chi square test was applied to test the association between two
categorical factors. All the tests of significance were applied at 5% level
of significance.
Statistical software: The package EPI-INFO version 3.5.3 was
used for  the analysis  of  the data and Microsoft  Excel  was used for  data
entry as well as to generate graphs, tables etc.
STATISTICAL METHODS
Lipid profile parameters were considered as primary outcome
variables. Birth weight category(normal birth weight Vs  low birth
weight),  Gender,  AGA Vs  SGA was  considered  as  primary  explanatory
variable.
All Lipid profile parameters like triglycerides, total cholesterol,
VLDL cholesterol, LDL cholesterol, HDL cholesterol were checked for
normal distribution within each category of birth weight category by
using visual inspection of histograms and normality Q-Q plots. Shapiro-
wilk test was also conducted to assess normal distribution.  Shapiro wilk
test p value of >0.05 was considered as normal distribution.
For normally distributed Lipid profile parameters the mean values
were compared between study groups using Independent sample t-test (2
groups) P value < 0.05 was considered statistically significant. IBM SPSS
version 22 was used for statistical analysis.(1)
1. IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY: IBM Corp.
50.00%50.00%
OBSERVATION AND RESULTS
A total of 100 subjects were included in the final analysis.
Table 1
Descriptive analysis of birth weight category in the study
population (N=100)
Birth weight category Frequency Percentages
Normal birth weight 50 50.00%
Low birth weight 50 50.00%
Figure 5
Pie chart of birth weight category in the study population (N=100)
Table 2
Descriptive analysis of lipid profile in the study population (N=100)
Parameter Mean ± SD Median Min Max
95% C.I
Lower Upper
Triglycerides
(mg/dl) 52.81± 11.73 52.00 32.00 76.00 50.48 55.14
Total Cholesterol
(mg/dl) 94.64 ± 10.89 95.00 70.00 107.00 92.48 96.80
VLDL Cholesterol
(mg/dl) 10.29 ± 2.87 10.00 5.00 16.00 9.72 10.86
LDL Cholesterol
(mg/dl) 66.24 ± 5.06 66.50 52.00 76.00 65.24 67.24
HDL Cholesterol
(mg/dl) 23.94 ± 2.41 24.00 19.00 29.00 23.46 24.42
The mean total cholesterol was 94.64 ± 10.89in the study
population, range between 70 mg/dl to 107 mg/dl in the study population
(95% CI 92.48 to 96.80). The mean triglyceride was 52.81 ± 11.73in the
study population, range between 32 mg/dl to 76 mg/dl in the study
population (95% CI 50.48to 553.14). The mean HDLcholesterol was
23.94 ± 2.41in the study population, range between 19 mg/dl to 29 mg/dl
in the study population (95% CI 23.46 to 24.42). The mean
LDLcholesterol was 66.24 ± 5.06in the study population, range between
52 mg/dl to 76 mg/dl in the study population (95% CI 65.24 to 67.24).
The mean VLDLcholesterol was 10.29 ± 2.87in the study population,
range between 5 mg/dl to 16 mg/dl in the study population (95% CI 9.72
to 10.86). (Table 2)
Table 3
Comparison of mean of lipid profile parameters between Birth
weight category (N=100)
lipid profile
Parameter
Birth weight category
P valueNormal birth
weight (N=50)
Low birth weight
(N=50)
Total Cholesterol
(mg/dl) 93.94 ± 4.35 95.34 ± 14.82 0.523
Triglycerides (mg/dl) 42.72 ± 5.38 62.9 ± 6.43 <0.001
HDL Cholesterol
(mg/dl) 23.44 ± 2.56 24.44 ± 2.16 0.037
LDL Cholesterol
(mg/dl) 64.86 ± 4.29 67.62 ± 5.42 0.006
VLDL Cholesterol
(mg/dl) 7.88 ± 1.3 12.7 ± 1.75 <0.001
The mean Triglycerides of normal birth weight group was 42.72 ±
5.38(mg/dl)and low birth weightgroup was 62.9 ± 6.43(mg/dl), and the
mean difference between two groups was statistically significant (P
value<0.001). The mean Total Cholesterol of normal birth weight group
was 93.94 ± 4.35(mg/dl)and low birth weightgroup was 95.34 ±
14.82(mg/dl), and the mean difference between two groups was
statistically not significant (P value 0.523). The mean HDL Cholesterol of
normal birth weight group was 23.44 ± 2.56 (mg/dl)and low birth
weightgroup was 24.44 ± 2.16(mg/dl), and the mean difference between
two groups was not statistically significant (P value 0.037). The mean
LDL Cholesterol of normal birth weight group was 64.86 ± 4.29
(mg/dl)and low birth weightgroup was 67.62 ± 5.42 (mg/dl), and the
mean difference between two groups was not statistically significant (P
value 0.006).  The mean VLDL Cholesterol of normal birth weight group
was 7.88 ± 1.3 (mg/dl)and low birth weightgroup was 12.7 ± 1.75
(mg/dl), and the mean difference between two groups was statistically
significant (P value<0.001). (Table 3 & Figure 2 to 6)
Table 4
Comparison of mean triglycerides (mg/dl) between birth weight
category(N=100)
Birth weight
category
Triglycerides
(mg/dl)
Mean± SD
Mean
difference
95% CI
P valueLower Upper
Normal birth weight 42.72 ± 5.38
20.18 17.83 22.53 <0.001
Low birth weight 62.9 ± 6.43
Figure 6
Error bar diagram of Comparison of mean triglycerides (mg/dl)
between birth weight category (N=100)
This Diagram shows significant difference in Triglycerides level in
between Normal and Low birth weight babies.
Table 5
Comparison of mean total cholesterol (mg/dl) between birth weight
category (N=100)
birth weight
category
Total
Cholesterol
(mg/dl)
Mean± SD
Mean
difference
95% CI
P value
Lower Upper
Normal birth
weight
93.94 ± 4.35
1.40 -2.93 5.73 0.523
Low birth weight 95.34 ± 14.82
Figure 7
Error bar diagram of comparison of mean total cholesterol
(mg/dl)between birth weight category (N=100)
This Diagram shows no significant difference in Cholesterol level
in between Normal and Low birth weight babies.
Table 6
Comparison of mean VLDL cholesterol (mg/dl) between study
groups (N=100)
Birth weight
category
VLDL cholesterol
(mg/dl)
Mean± SD
Mean
difference
95% CI
P value
Lower Upper
Normal birth
weight
7.88 ± 1.3
4.82 4.21 5.43 <0.001
Low birth weight 12.7 ± 1.75
Figure 8
Error bar diagram of comparison of mean VLDL cholesterol (mg/dl)
between birth weight category (N=100)
This Diagram shows significant difference in VLDL level in
between Normal and Low birth weight babies.
Table 7
Comparison of mean LDL cholesterol (mg/dl) between birth weight
category (N=100)
Birth weight
category
LDL
cholesterol
(mg/dl) Mean
± SD
Mean
difference
95% CI
P value
Lower Upper
Normal birth weight 64.86 ± 4.29
2.76 0.82 4.70 0.006
Low birth weight 67.62 ± 5.42
Figure 9
Error bar diagram of comparison of mean LDL cholesterol (mg/dl)
between birth weight category (N=100)
This Diagram shows no significant difference in LDL level in
between Normal and Low birth weight babies.
Table 8
Comparison of mean HDL cholesterol (mg/dl) between birth weight
category(N=100)
Birth weight
category
HDL cholesterol
(mg/dl)
Mean± STD
Mean
difference
95% CI
P value
Lower Upper
Normal birth
weight
23.44 ± 2.56
1.00 0.06 1.94 0.037
Low birth weight 24.44 ± 2.16
Figure 10
Error bar diagram of comparison of mean HDL cholesterol (mg/dl)
between birth weight category (N=100)
This Diagram shows no significant difference in HDL level in
between Normal and Low birth weight babies.
Table 9
Comparison of gender in study population(N=100)
Gender
Chi
square
P-value
BOYS (N=48) GIRLS (N=52)
48 (48%) 52 (52%) 0.160 0.689
Figure 11
Pie chart of baby gender in the study population (N=100)
48.00%
52.00%
Boy
Girl
Table 10
Comparison of mean of lipid profile parameters between Boys and
Girls (N=100)
Lipid Parameter
Gender
P value
Boys(N=57) Girls (N=43)
Triglycerides (mg/dl) 52.99 ± 11.48 52.25 ± 12.73 0.790
Total Cholesterol (mg/dl) 94.08 ± 12.06 96.42 ± 5.65 0.362
HDL Cholesterol (mg/dl) 23.84 ± 2.33 24.25 ± 2.66 0.472
LDL Cholesterol (mg/dl) 66.71 ± 5.18 64.75 ± 4.43 0.098
VLDL Cholesterol (mg/dl) 10.5 ± 2.69 9.63 ± 3.36 0.194
The mean triglycerides of Boys group was 52.99 ±
11.48(mg/dl)and 30  Girls group was 52.25 ± 12.73(mg/dl), and the mean
difference between two groups was statistically not significant (P
value0.790).  The mean Total Cholesterol of Boys group was 94.08 ±
12.06(mg/dl)and  Girls  group was 96.42 ± 5.65(mg/dl), and the mean
difference between two groups was statistically not significant (P value
0.362). The mean HDL Cholesterol of Boys group was 23.84 ±
2.33(mg/dl)and Girls  group was 24.25 ± 2.66(mg/dl), and the mean
difference between two groups was statistically not significant (P value
0.472). The mean LDL Cholesterol of Boys group was 66.71 ±
5.18(mg/dl)and Girls group was 64.75 ± 4.43(mg/dl), and the mean
difference between two groups was statistically not significant (P value
0.098).   The  mean  VLDL  Cholesterol  of  Boys  group  was  10.5  ±
2.69(mg/dl)and Girls  group was 9.63 ± 3.36(mg/dl), and the mean
difference between two groups was statistically not significant (P
value0.194). (Table 8)
Table 11
Descriptive analysis of gravida in study population (N=100)
Gravida Frequency Percentage
Primi 34 34.00%
Multi 66 66.00%
Among the study population, 34% women participants had primi
gravida and 66% women participants had multi gravida. (Table 5).
Figure 12
Pie chart of gravida in study population (N=100)
This pie chart showing 34 primi, 66 multi New Born babies are
studied in this group.
MULTI
66%
PRIMI
34%
Chart Title
Table 12
Comparison of mean of lipid profile parameters between gravida
groups (N=100)
Parameter
Gravida
P value
PRIMI (N=34) Multi (N=66)
Triglycerides (mg/dl) 52.32 ± 12.02 53.06 ± 11.66 0.768
Total Cholesterol (mg/dl) 95.65 ± 5.91 94.12 ± 12.73 0.510
HDL Cholesterol (mg/dl) 24.06 ± 2.21 23.88 ± 2.51 0.725
LDL Cholesterol (mg/dl) 67.79 ± 3.96 65.44 ± 5.39 0.027
VLDL Cholesterol (mg/dl) 10.47 ± 2.98 10.2 ± 2.83 0.654
The mean triglycerides of primi gravida group was 52.32 ± 12.02
(mg/dl) and multi gravidagroup was 53.06 ± 11.66 (mg/dl), and the mean
difference between two groups was statistically not significant (P value
0.768).  The mean total cholesterol of primi gravida group was 95.65 ±
5.91 (mg/dl) and multi gravidagroup was 94.12 ± 12.73 (mg/dl), and the
mean difference between two groups was statistically not significant (P
value 0.510). The mean HDL Cholesterol of primi gravida group was
24.06 ± 2.21 (mg/dl) and multi gravidagroup was 23.88 ± 2.51 (mg/dl),
and the mean difference between two groups was statistically not
significant (P value 0.725). The mean LDL Cholesterol of primi gravida
group was 67.79 ± 3.96 (mg/dl) and multi gravidagroup was 65.44 ± 5.39
(mg/dl), and the mean difference between two groups was statistically
significant (P value 0.027).  The mean VLDL Cholesterol of primi
gravida group was 10.47 ± 2.98 (mg/dl) and multi gravidagroup was 10.2
± 2.83 (mg/dl), and the mean difference between two groups was
statistically not significant (P value 0.654) (Table 7).
Table 13
Descriptive analysis of AGA vs SGA in study population (N=100)
Frequency Percentage
AGA 68 68.00%
SGA 32 32.00%
Among the study population, 68% neonates came under AGA
category and 32% neonates acme under SGA category.. babies are
categorized in groups by use of AIIMS intrauterine growth charts.
AGA
68%
SGA
32%
Chart Title
Figure 13
Pie chart of AGA vs  SGA in study population (N=100)
This  pie  chart  showing  32  SGA,  68  AGA  New  Born  babies  are
studied in this group.
Table 14
 Comparison of mean of lipid profile parameters between AGA
and SGA category (N=100)
lipid profile Parameter
Birth weight category
P value
AGA (N=68) SGA (N=32)
Total Cholesterol (mg/dl) 91.94 ± 4.35 96.34 ± 14.82 0.523
Triglycerides (mg/dl) 40.72 ± 7.38 64.9 ± 8.43 <0.001
HDL Cholesterol (mg/dl) 24.44 ± 2.56 22.44 ± 3.16 0.037
LDL Cholesterol (mg/dl) 62.86 ± 4.29 64.62 ± 5.42 0.006
VLDL Cholesterol (mg/dl) 7.88 ± 1.3 8.74 ± 1.75 0.009
The mean triglycerides of AGA group was 40.72 ± 7.38 (mg/dl)
and SGA group was 64.9 ± 8.43 (mg/dl), and the mean difference
between two groups was statistically significant (P value <0.001).
The mean total cholesterol of AGA group was 91.94 ± 4.35 (mg/dl)
and SGA group was  96.34 ± 14.82 (mg/dl), and the mean difference
between two groups was statistically not significant (P value 0.523). The
mean HDL Cholesterol of AGA group was 24.44 ± 2.56 (mg/dl) and
SGA  group was  22.44 ± 3.16 (mg/dl), and the mean difference between
two groups was statistically not significant (P value 0.037).Here the HDL
cholesterol level was low in SGA babies. The mean LDL Cholesterol of
AGA  group was 62.86 ± 4.29 (mg/dl) and  SGA  group was 64.62 ± 5.42
(mg/dl), and the mean difference between two groups was statistically
significant (P value 0.006).  The mean VLDL Cholesterol of AGA group
was 7.88 ± 1.3 (mg/dl) and SGA group was 8.74 ± 1.75 (mg/dl), and the
mean difference between two groups was statistically not significant (P
value 0.009) (Table 7).
DISCUSSION
Recently interest in cord lipids has increased because serum lipid
disorders have their roots in childhood and atherogenic changes are
postulated to originate early in life.
Lipid profile is a marker of an underlying cardiovascular status,
and there is direct correlation between the abnormalities in lipid profile
and occurrence of cardiovascular morbidities and mortality.
Levels of Lipids and Lipoproteins in the cord sera should be a
reflection of the status of plasma lipid metabolism in the infant at birth
because most fetal Lipids are synthesized de novo through the conversion
of glucose to various fatty acid containing compounds. Only part of it is
derived from placental circulation, so measurement of cord blood Lipid
profile will be like measuring Lipid metabolism during fetal life and at
birth.
Among various factors theorised in the development of
atherosclerosis, increased plasma levels of cholesterol and/or
triglycerides are considered to be most important. Furthermore a number
of investigators now consider only LDL and HDL as major risk factors
on the development and progression of atherosclerotic vascular diseases.
Hence determinations of cord lipid profile becomes a useful tool in
the earlier detection of babies at a higher risk, since several investigators
believe that the atherosclerotic lesions may have its genesis in childhood.
There are many studies showing direct relationship between the
abnormalities in lipid profile among the preterm and SGA neonates and
occurrence of cardiovascular diseases. The present study was undertaken
for early detection of abnormalities in the lipid profile at the earliest (at
birth), especially in the preterm and SGA neonates, so that these high risk
babies can be under vigilant monitoring in future.
Table 15
Comparision Of Influence Of Gender On Neonate  Cord Blood Lipid
Profile
LIPID
PROFILE
PRESENT
STUDY
JAGADISH
SINGH ET
AL
BADIEE Z
ET AL
KHALID
MIRZA ET
AL
BOY GIRL BOY GIRL BOY GIRL BOY GIRL
Total
cholesterol
94.08±
12.06
96.42±
5.65
88.7
0±
19.1
91.1
0±
17.2
75.2
0±
21.1
81.40
±
8.10*
166.
03±
06.9
9
166.8
0±
06.64
*
Triglycerid
es
52.99±
11.48
52.25±
12.73
- - 61.0
0±
02.0
62.00
±
2.00
56.3
0±0
6.83
59.2
9±
06.1
6
HDL 23.84±
 2.33
24.25±
2.66
- - - -
LDL 66.71±
5.18
64.75±
4.43
- - 32.1
0±16
.30
35.90
±
2.40
- -
VLDL 10.50±
2.69
9.63±
3.36
- - 28.8
0±08
.70
31.18
±
9.97*
74.6
8±0
7.11
75.14
±
05.83
*
As per  the  table  shown above  in  the  present  study  among males
and females the cord lipid profile values were approximately equal with
no statistically significant p value.
Similar observations were made by Jagadish Singh et al.26 but in
Badiee z et al.31 Khalid Mirza et al.92 Female neonates had significantly
higher TC and HDL (p=<0.05, p=<0.05 respectively), but LDL value
was higher in females but it was not statistically significant.
TABLE 16
COMPARISION OF INFLUENCE OF BIRTH WEIGHT OF
NEONATE ON CORD LIPID PROFILE
Lipid
profile
Present study A Kalra
et al study
N.Haridas
and P.T.
Acharya
et al
Jagadish
singh et al
Study
Birth  weight NBW
>2.5
kg
LBW
<2.5kg
NBW LBW NBW LBW NBW LBW
Total
cholesterol
93.94±
4.35
95.34±
14.82
76.6 ±
24.4
67.8±
10.8
90.0±
20.2
95.00
± 20.2
96.5±
15.1
69.5±
10.9
Triglycerides 42.72±
5.38
62.90±
6.43
- - 45.0±
13.8
59.1±
22.30
- -
VLDL 7.88±
1.30
12.70±
1.75
- - - - - -
LDL 64.86±
4.29
67.62±
5.42
20.7±
5.8
19.5±
0.7
- - - -
HDL 23.44±
2.56
24.44±
2.16
22.5±
6.5
20.5±
7.3
- - - -
As  per  the  table  shown  above  in  the  present  study  LOW  birth
weight babies had significantly elevated lipid parameters such as Total
cholesterol, Triglycerides, LDL, HDL, VLDL but TG  and VLDL
values only statistically increased (P<0.005)  in LOW birth weight
babies than NORMAL birth weight babies.
 N.Harias and P.T.Acharya et al.15 in their study concluded that
Low  birth  weight  neonates  have  higher  TG  and  TC  levels  but
statistically significant difference was found only in TC (p<0.001)
levels.
Mathur et  al.16 in their study concluded that in Low birth weight
neonates, TC value was significantly high (p<0.001).
Jane Oba et al.28 in  their  study  concluded  that  TC,  LDL,  HDL
values were significantly higher in Low birth weight neonates
(p<0.0001), TG value was significantly higher in Low birth weight
neonates (p<0.01).
Pardo  et  al.11 in  their  study  concluded  that  TC,  LDL,  HDL were
higher in Low birth weight neonates compared to Normal birth weight
neonates with statistically significant difference in TC and LDL
(p<0.001) levels, but HDL had no statistically significant difference. AI
values were more in low birth weight compared to normal babies which
was not statistically significant.
A K Kalra et al.17 in their study concluded that all Cord lipid
profile values were lower in low birth weight neonates compared to
normal birth weight neonates but statistically significant difference was
found with TC levels (p <0.001) and no statistically significant
difference was found with HDL and LDL levels.
Jagadish Singh et al.26 in their study concluded that normal
neonates had higher TC compared to low birth weight neonates with
statistically significant difference (p<0.05).
Table  17
Comparision Of Influence Of Birth Weight (Aga   Vs   Sga)
Irrespective Of Gestational Age Of Newborn On Cord Blood Lipid
Profile
Lipid
Profile
Present
study
Tejasree
katragadda
Et al  study
Jane  Oba
et al Study
Ajay Kumar
et al. Study
AGA SGA AGA SGA AGA SGA AGA SGA
TC
(mg/dl)
91.94 ±
4.35
96.34 ±
14.82
85.4±
22
83.6±
31.6
57±19 57±19 85.83±
22.85
92.2±
8.32
TGL
(mg/dl)
40.72 ±
7.38
64.9 ±
8.43
55.5±
26
74.5±
39.9
42±25 42±25 35.27±
17.49
104.5±
20.8*
HDL
(mg/dl)
24.44 ±
2.56
22.44 ±
3.16
36.3±
12
32.5±
13.3
30±14 30±14 - -
LDL
(mg/dl)
62.86 ±
4.29
64.62 ±
5.42
39.6±
5
38.8±
23.8
19±8 19±8 - -
VLDL
(mg/dl)
7.88 ±
1.3
8.74 ±
1.75
- - - - - -
AGA – Appropriate for gestational age
SGA-  Small for gestational age
As per table shown above, in present study in SGA neonates cord
blood Triglycerides, Total cholesterol, LDL, VLDL levels were
elevated  and HDL levels were decreased compared to AGA neonates.
But statistically only Triglycerides level alone elevated in SGA babies
(P<0.005)..  This  can  be  explained  on  the  fact  that  Triglyceride  and
VLDL, its synthesis is increased in SGA babies and also its metabolism
is decreased due to decreased activity of lipoprotein lipase.23
Jane Oba et al.28 in their study they concluded that Preterm SGA
had higher values of TC, TG, LDL, HDL compared to Preterm AGA
which was statistically significant with P values <0.0001, <0.01,
<0.0001, <0.0001 respectively and Term SGA had higher values of TC,
TG, LDL, HDL compared to term AGA which was statistically
significant with P values <0.0001, <0.01, <0.0001,<0.0001 respectively.
Ajay Kumar et al.19 in their study they concluded that Term AGA
and Preterm AGA had higher values of TC compared to Term SGA and
Preterm SGA but values were not statistically significant. Term SGA
and Preterm SGA had higher TG value compared to Term AGA and
Preterm AGA values which were statistically significant (p=<0.05).
Tejasree katragadda et al study in their they found that SGA
babies had elevated lipid parameters with statistically significant values
in Triglycerides.
Low birth weight infants are born with intra uterine malnutrition
.Such circumstances favour fetal adipose tissue break down liberating
free fatty acids, which escapes oxidation for energy, is synthesized in the
liver into triglyceride, which causes elevated levels of Triglyceride in
low birth weight babies .Intrauterine malnutrition could be result of
placental insufficiency.19
The prevalent concept is, having bad habits in adult life, such as
being sedentary, eating a high fat diet and smoking cause coronary heart
disease .The fetal hypothesis does not deny the importance of these adult
factors , it simply adds another layer to the complex and multifactorial
etiology of the disease, suggesting that in addition to genetic factors and
life style factors fetal nutrition needs to be considered a risk factor.
There have been studies to show that coronary heart disease has its roots
traceably to infancy. Hyperlipoprotenemia at birth is one of the risk
factors for developing coronary artery disease later in life.28
In our study there is an increase in the cord blood levels of Total
Cholesterol in preterm newborns and an elevated TG levels in low birth
weight newborns. This suggests that a fetus receiving inadequate
nutrition has to make adaptations in order to survive and may be prone
to hyperlipidemia. Thus strategy to prevent coronary heart disease must
include measures to improve fetal growth and early detection of
hyperlipidemia with dietary intervention during infancy and later
childhood.
In the present study cord blood lipid profile values in SGA were
elevated when compared to AGA, the reason is that, there is lack of
glucose as fuel in SGA babies, so these babies use alternative source as a
fuel (amino acid and lipids) and generate glucose (gluconeogenesis),
where by activating lipid and other metabolism, so there will be
increased hepatic generation of lipids (particularly VLDL and
chylomicrons) also, there is decreased peripheral utilization of lipids
because of decreased activity of lipoprotein lipase enzyme in growth
restricted babies, these two facts explain higher concentration of plasma
lipids in SGA babies.9,11,
Barker  hypothesis  demonstrated  that  low birth weight
correlated with an increased prevalence of Cardiovascular disease,
hypertension and  type 2 diabetes mellitus and suggested that  this
association reflects  the phenomenon known as  programming, whereby
a stimulation or insult  during a critical period of  intrauterine life  could
also result in  alterations of physiology and  metabolism during  adult
life.
So those born with low  weight at birth need more follow up  in
their latter life.
CONCLUSIONS
The following conclusions were drawn from this study:
GENDER:
There was no statistically significant difference in cord lipid profile
between males and females in both term and preterm neonates.
BIRTH WEIGHT:
Cord blood Lipid profile values for TG, and VLDL were
significantly higher (P<0.005)  in low birth weight babies compared to
normal birth weight babies.
Cord  blood  lipid  profile  values  for  TC,  HDL  and  LDL  were  not
significantly higher in low birth weight babies.
AGA/SGA:
Cord blood lipid profile values for TG was significantly higher in
SGA babies P<0.005 compared to AGA babies.
SUMMARY
The objective of  the present  study was to know the abnormalities
in the cord blood lipid profile values in low birth weight neonates
compared to normal birth weight neonates as well as SGA neonates
compared to AGA neonates.
After taking written informed consent, relevant maternal data was
collected; cord blood was collected immediately after the delivery, blood
was allowed to clot  for  separation of  the serum and then sent  to lab for
further analysis. The babies were examined and all relevant
anthropometric variables were recorded and then babies were classified
into NORMAL and LOW BIRTH WEIGHT based on birth weight, SGA
or AGA group with the use of AIIMS Intrauterine growth charts and
Ponderal index.
This hospital based case control study was conducted from March
2018 to august 2018 enrolling 100 neonates of which 50 babies were
above 2.5 kg and 50 were below 2.5 kg..Of which 48 were boys and 52
were girls. Out of 100 neonates, 68 were AGA, 32 were SGA.
Majority of the neonates in our study were females (52%).. Among
AGA, male neonates were more (60.2%) and among SGA, female
neonates were more (48.5%) but there was no statistically significant
difference in gender distribution amongst any groups.
Cord lipid profile values were higher in LOW birth weight
neonates compared to NORMAL birth weight neonates.
Cord lipid profile values were higher in SGA neonates compared
to AGA neonates except for HDL (32.77±09.57), which was lower in
SGA neonate.
Cord lipid profiles values in LOW birth weight neonates were –
TG (62.9 ± 6.43), TC (95.34 ± 14.82), HDL(24.44 ± 2.16), LDL(67.62 ±
5.42), VLDL (12.7 ± 1.75). Cord lipid profiles values in NORMAL birth
weight neonates – TC (93.94 ± 4.35), TG (42.72 ± 5.38), HDL (23.44 ±
2.56), LDL (64.86 ± 4.29), VLDL (7.88 ± 1.3).In Cord lipid profile
values  total cholesterol and VLDL values were higher in  LOW birth
weight neonates compared to NORMAL birth wight neonates, which
were statistically significant (P<0.005).
Cord  lipid  profile  values  in  SGA  neonates  were  –  TC
(96.34±14.82), TG (64.9±8.43), HDL(22.44±3.16), LDL(64.62±5.42)
VLDL (8.73±1.75). Cord lipid profile values in AGA neonates were –
TC (91.94±4.35), TG (40.72±7.38), HDL (24.44±2.56), LDL
(62.86±4.29), VLDL (7.88±1.33). Cord lipid profile values  Triglycerides
were higher in SGA neonates which were statistically significant
(p<0.005) compared to AGA neonates.. HDL level was lower in SGA
neonate but statistically not significant.
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LIST OF ABBREVIATIONS
AGA Appropriate for Gestational Age
AI Atherogenic index
ANC Ante Natal check up
APOA Apolipoprotein A
APOB Apolipoprotein B
ATP Adenosine
B.Wt Birth weight
CAD Coronary artery disease
CHD Coronary heart disease
COA Coenzyme A
DM Diabetes mellitus
EFA Essential fatty acid
ELBW Extremely low Birth weight
FFA Free fatty acid
GA Gestational age
HC Head circumference
HDL High density Lipoproteins
IDL Intermediate density lipoprotein
IUGR Intra uterine growth retardation
LBW Low birth weight
LDL Low density Lipoproteins
Leng Length
LGA Large for Gestational age
LPL Lipo protein lipase
PE Pre-eclampsia
PI Ponderal index
PIH Pregnancy induced
hypertention
PT Preterm
SD Standard deviation
SGA Small for gestational age
T Term
TC Total cholesterol
TG Triglyceride
VLBW Very low birth weight
VLDL Very low density
lipoprotein
PROFORMA
COMPARATIVE STUDY ON UMBILICAL CORD BLOOD LIPID
PROFILE BETWEEN NORMAL AND LOW BIRTH WEIGHT
? NAME:   B/O                                                                              DATE:
?   SEX:
?   BIRTH WEIGHT:
ANTENATAL HISTORY:
GRAVIDA:                      LMP:                    EDD:
                                           GESTATIONAL AGE:
MATERNAL MEDICAL COMORBIDITIES:
MATERNAL MEDICATIONS:
PERINATAL EVENTS
PROLONGED SECOND STAGE OF LABOUR:
RISK OF SEPSIS:
COLOUR OF LIQUOR:
EVIDENCE OF FOETAL DISTRESS:
NATAL HISTORY
MODE OF DELIVERY:
INDICATION;
      ( if  LSCS)
APGAR:
     1 MIN:                                     5 MIN:
GENERAL EXAMINATION
GESTATIONAL AGE  BY BALLORD SCORE:
HR:                       RR:
LENGTH:                           HEAD CIRCUMFERENCE:
SYSTEMIC EXAMINATION
CVS:
RS:
P/A:
CNS:
INVESTIGATIONS
1.  TRIGLYCERIDES
2.  TOTAL CHOLESTEROL
3.  VLDL
4.  LDL
5.  HDL
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PATIENT CONSENT FORM
Study detail “COMPARATIVE STUDY ON UMBILICAL CORD
BLOOD LIPID PROFILE BETWEEN NORMAL AND LOW BIRTH
WEIGHT ”
Study centre :              KILPAUK  MEDICAL  COLLEGE,
CHENNAI
Patients Name :
Patients Age :
Identification Number        :
Patient may check ( ? ) these boxes
I  confirm that I have understood the purpose of procedure for the above
study. I have the opportunity to ask question and all my questions and
doubts have been answered to my complete satisfaction.
I understand that my participation in the study is voluntary and that I am
free to withdraw at any time without giving reason, without my legal
rights being affected.
I understand that sponsor of the clinical study, others working on the
sponsor’s behalf, the ethical committee and the regulatory authorities
will not need my permission to look at my health records, both in
respect of current study and any further research that may be conducted
in relation to it, even if I withdraw from the study I agree to this access.
However, I understand that my identity will not be revealed in any
information released to third parties or published, unless as required
under the law. I agree not to restrict the use of any data or results that
arise from this study.
I agree to take part in the above study and to comply with the
instructions given during the study and faithfully cooperate with the
study team and to immediately inform the study staff if I suffer from
any deterioration in my health or well-being or any unexpected or
unusual symptoms.
I hereby consent to participate in this study.
I hereby give permission to undergo complete clinical examination and
diagnostic tests including hematological, biochemical, radiological tests.
Signature/thumb impression:
Patients Name and Address:  place date
Signature of investigator :
Study investigator’s Name :                     place date
S.NO                     NAME
 BIRTH
WEIGHT
  AGA/
SGA      SEX GRAVIDA
LIPID
PROFILE
TG TC VLDL LDL HDL
1 B/O  THARANI MOHAN 3.2 AGA GIRL PRIMI 48 96 9 68 26
2  B/O VANITHA DINESHKUMAR 2.7 SGA BOY MULTI 52 92 9 69 25
3 B/O KALAVATHY ILAIYARAJA 2.6 SGA BOY PRIMI 42 91 8 65 20
4 B/O MAHALAKSHMI ARUN 3.5 AGA GIRL PRIMI 44 99 10 74 26
5 B/O SHANTHI RAGU 3.6 AGA GIRL MULTI 36 102 9 72 24
6 B/O REKHA VIJAY 2.8 AGA GIRL MULTI 46 92 7 58 27
7 B/O LATHA VIJAYKUMAR 2.84 AGA GIRL MULTI 38 90 8 56 21
8 B/O  NEEJA VIGNESH 3.5 AGA BOY PRIMI 52 86 5 66 24
9 B/O VIJAYA KAMESH 2.64 SGA GIRL PRIMI 56 98 9 62 26
10 B/O INDIRA NAGARAJ 2.96 SGA BOY MULTI 42 95 8 64 22
11 B/O PRIYA RAMESH 3.1 AGA BOY MULTI 46 93 9 68 20
12 B/O NANDHINI PARTHIBAN 3.4 AGA BOY MULTI 39 90 7 58 19
13 B/O AISHWARYA SURESH 3.17 AGA GIRL PRIMI 47 87 9 69 22
14 B/O RAJKUMARI KUMAR 2.74 AGA GIRL MULTI 39 99 10 67 20
15 B/O USHA THANGAM 2.58 SGA BOY MULTI 45 102 8 62 21
16 B/O RADHA UDHAYASANKAR 2.64 SGA GIRL PRIMI 47 100 9 66 26
17 B/O PAVITHRA NAGARAJ 2.96 SGA BOY MULTI 48 103 6 61 25
18 B/O DHIVYA BHARATH 2.65 SGA GIRL MULTI 42 100 9 68 24
19 B/O MENAKA MANIKANDAN 2.69 SGA BOY PRIMI 40 94 7 72 26
20 B/O  RADHA JAGANATHAN 2.79 AGA GIRL PRIMI 36 92 8 60 28
21 B/O  POONGODI NAGARAJ 3.42 AGA BOY PRIMI 38 97 7 68 21
22 B/O  PRIYA KARTHIK 2.85 SGA BOY MULTI 47 95 9 65 20
23 B/O JOTHI SANKAR 3.45 AGA GIRL MULTI 40 98 10 63 29
24 B/O GEETHA BALAJI 3.6 AGA BOY MULTI 44 92 8 68 23
25 B/O JESSI CORAL 2.64 SGA BOY PRIMI 42 90 9 66 22
26 B/O FOHINI NAGARAJ 2.74 SGA GIRL MULTI 52 100 7 69 20
27 B/O VENDAMANI PRASANTH 3.11 AGA BOY MULTI 46 94 6 60 19
28 B/O DHANALAKSHMI VINAI 3.25 AGA GIRL PRIMI 39 92 9 58 26
29 B/O RAMYA SANTHOSH 2.94 AGA BOY MULTI 36 97 8 66 25
30 B/O SANGEETHA LOGESH 2.86 AGA BOY MULTI 39 95 6 68 21
31 B/O JAMUNA BALA 2.68 AGA GIRL PRIMI 37 94 8 69 24
32 B/O SARASHWATHY NAVEEN 2.73 SGA GIRL MULTI 42 93 5 71 22
33 B/O MOHANA  MATHI 2.93 AGA BOY MULTI 43 88 5 66 27
34 B/O SALOMI  ALEX 2.76 SGA BOY PRIMI 49 87 9 62 25
35 B/O  JOTHI KANI PRASANTH 3.51 AGA BOY MULTI 50 96 8 61 23
36 B/O GOMATHY ASHOK 3.64 AGA BOY PRIMI 38 95 9 60 24
37 B/O  DEEPIKA SARAVANAN 2.52 AGA GIRL PRIMI 36 90 7 70 22
38 B/O INDHU RAGHU 2.56 AGA GIRL PRIMI 39 98 6 62 21
39 B/O UMAMAHWSHWARI GURU 2.62 SGA BOY MULTI 42 93 7 66 26
40 B/O MONISHA CHANDRU 2.94 SGA BOY MULTI 47 97 8 65 25
41 B/O TAMILSELVI PRAKASH 2.67 AGA BOY PRIMI 43 92 9 61 22
42 B/O SABIYA FAIZAL 2.68 SGA GIRL MULTI 41 90 8 60 24
43 B/O VANDANA BALAJI 2.63 AGA GIRL PRIMI 38 88 8 70 27
44 B/O BLESSY SURESH 2.78 AGA GIRL MULTI 37 92 6 66 26
45 B/O SAKUNDALA  AJAY 2.64 AGA GIRL MULTI 32 94 7 67 25
46 B/O ANANDHI  ADIYAMAN 2.94 AGA GIRL MULTI 39 93 8 62 21
47 B/O RADHA RAVICHANDRAN 3.14 AGA GIRL PRIMI 49 92 9 60 20
48
B/O BHUVANESHWARI
SANTHOSH 2.65 SGA GIRL MULTI 51 86 7 62 24
49 B/O  DHIVYA SREENI 3.45 AGA GIRL MULTI 36 99 9 68 22
50 B/O KAVITHA  SATHYAN 3.65 AGA GIRL MULTI 39 89 8 59 24
51
B/O SUNDRAMBAL
SUBRAMANI 2.21 SGA BOY MULTI 62 98 13 68 24
52 B/O SANTHI RAGHU 2.12 AGA GIRL PRIMI 66 103 15 69 26
53 B/O LAKSHMI SELVARAJ 2.38 SGA BOY MULTI 70 102 14 58 22
54 B/O ANJALI  JORDAN 2.38 AGA BOY PRIMI 50 105 15 70 25
55 B/O THENMOZHI MAHESH 2.19 AGA GIRL PRIMI 55 86 12 72 24
56 B/O SUDHA PRAKASH 2.09 AGA GIRL MULTI 54 95 10 68 26
57 B/O JAYA MOHAN 2.08 AGA BOY MULTI 59 90 11 60 27
58 B/O LAVANYA  SURESH 2.37 AGA GIRL MULTI 55 92 11 62 21
59 B/O RANJITHA KUMAR 2.16 SGA BOY MULTI 72 106 14 68 26
60 B/O MYTHILI 2.46 AGA BOY MULTI 59 92 12 74 25
61 B/O SELVI 2.3 SGA GIRL PRIMI 74 106 11 66 26
62 B/O SOWMYA 2.16 AGA GIRL MULTI 72 100 13 70 26
63 B/O ANITHA 2.05 SGA BOY PRIMI 68 96 15 74 24
64 B/O RAJKUMARI KUMAR 2.43 AGA GIRL MULTI 60 94 12 76 25
65 B/O KAVEERI 2.34 SGA BOY MULTI 66 95 13 74 22
66 B/O NIKITHA 2.31 AGA GIRL MULTI 58 94 15 70 20
67 B/O AMBHIKA 2.01 AGA GIRL MULTI 57 96 14 65 26
68 B/O PADMAVATHY 2 AGA BOY PRIMI 65 95 11 62 25
69 B/O AMUL 1.97 AGA GIRL PRIMI 60 106 10 66 24
70 B/O LATHA VIJAYKUMAR 2.39 AGA BOY MULTI 62 105 12 74 26
71 B/O SHALINI 2.4 SGA GIRL MULTI 61 101 12 60 28
72 B/O REENA 1.86 AGA BOY PRIMI 59 98 14 68 24
73 B/O GANGA DEVI 2.03 AGA GIRL MULTI 74 107 11 65 23
74 B/O MICHEL RANI 2.35 AGA BOY MULTI 69 100 15 67 22
75 B/O DHANALAKSHMI VINAI 2.14 AGA GIRL MULTI 64 96 16 69 26
76 B/O SARANYA 2.35 AGA GIRL PRIMI 66 92 12 75 21
77 B/O MAKESHWARI 2.41 AGA BOY MULTI 58 90 14 60 20
78 B/O SARALA 2.12 SGA GIRL MULTI 62 94 12 68 26
79 B/O  SATHYA SENTHIL 2.35 AGA BOY MULTI 66 100 11 70 24
80 B/O SELVI MANIKANDAN 2.15 AGA GIRL MULTI 54 96 12 75 23
81 B/O RUBY GANDHI 2.3 AGA GIRL MULTI 62 96 10 72 25
82 B/O SANGEETHA SARAN 2.4 SGA GIRL MULTI 76 105 16 60 26
83 B/O PUSHPA LOGESH 2.35 SGA BOY PRIMI 72 98 15 66 22
84 B/O SALSA KAMAL 2.15 AGA GIRL MULTI 60 96 12 68 23
85 B/O PAVITHRA DEVI KARTHI 2.34 AGA BOY MULTI 68 102 14 72 26
86 B/O VIDHYA  MAHESH 2 AGA BOY PRIMI 64 104 11 74 27
87 B/O USHA RANI 2.46 SGA GIRL MULTI 70 105 15 60 22
88 B/O JANANI 1.95 AGA BOY PRIMI 58 92 13 65 29
89 B/O SAI VAISHNAVI 1.99 AGA GIRL MULTI 56 88 12 66 21
90 B/O ROSHINI 2.36 AGA BOY MULTI 50 89 11 70 24
91 B/O PARAMESHWARI 2.22 SGA GIRL MULTI 62 102 10 72 25
92 B/O BANU 2.1 SGA GIRL MULTI 66 0 13 75 27
93 B/O KAVITHA ANTONY 2.35 AGA BOY PRIMI 68 92 15 65 26
94 B/O LAVANYA  CHANDRU 2.14 AGA GIRL MULTI 56 96 10 56 26
95 B/O SINDHU 2.22 AGA BOY MULTI 66 94 13 52 28
96 B/O MONIKA 2.35 AGA BOY MULTI 58 100 12 68 25
97 B/O SINDHUJA 2.05 AGA BOY MULTI 64 98 14 69 22
98 B/O JAYAMALA 2.35 SGA BOY MULTI 68 95 13 66 23
99 B/O DHIVYA JAGAN 2.24 SGA BOY MULTI 70 99 14 72 22
100 B/O PREETHI 2.35 AGA GIRL PRIMI 54 86 10 70 26
